Amlopin M 5 Mg/50 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Amlopin M 5 Mg/50 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Amlopin M 5 Mg/50 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Amlopin M 5 Mg/50 Mg Tablet are Slow heart rate (pulse). Apart from the aforementioned side effects, Amlopin M 5 Mg/50 Mg Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Amlopin M 5 Mg/50 Mg Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Amlopin M 5 Mg/50 Mg Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Amlopin M 5 Mg/50 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Amlopin M 5 Mg/50 Mg Tablet related warnings section.
Amlopin M 5 Mg/50 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Amlopin M 5 Mg/50 Mg Tablet in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. Other contraindications of Amlopin M 5 Mg/50 Mg Tablet have been discussed in the sections ahead.
Drug interactions for Amlopin M 5 Mg/50 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Amlopin M 5 Mg/50 Mg Tablet is not safe while driving, and is is not addictive in nature.
Amlopin M 5 Mg/50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Amlopin M 5 Mg/50 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Amlopin M 5 Mg/50 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Amlopin M. If you are pregnant, do not take Amlopin M without a doctor's advice.
Is the use of Amlopin M 5 Mg/50 Mg Tablet safe during breastfeeding?
Breastfeeding women can take Amlopin M as it bears very minor side effects for them.
What is the effect of Amlopin M 5 Mg/50 Mg Tablet on the Kidneys?
Using Amlopin M does not have any harmful effects on kidneys.
What is the effect of Amlopin M 5 Mg/50 Mg Tablet on the Liver?
Amlopin M may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Amlopin M 5 Mg/50 Mg Tablet on the Heart?
Amlopin M may have mild side effects on the heart. Most people will never see any effect on the heart.
Amlopin M 5 Mg/50 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Amlopin M 5 Mg/50 Mg Tablet unless your doctor advises you to do so -
Is this Amlopin M 5 Mg/50 Mg Tablet habit forming or addictive?
No, there is no any evidence that Amlopin M 5 Mg/50 Mg Tablet is addictive.
Interaction between Food and Amlopin M 5 Mg/50 Mg Tablet
Taking Amlopin M 5 Mg/50 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Amlopin M 5 Mg/50 Mg Tablet
Consuming Amlopin M 5 Mg/50 Mg Tablet with alcohol can have many serious effects on your body.
Yes, Amlopin M can be taken with telmisartan. As per clinical studies, no harmful interaction has been reported after taking them. However, do not take it without doctors advise. A fixed-dose combination of Amlopin M and telmisartan is available in the market which is used for the treatment of hypertension (high blood pressure).
No, Amlopin M does not cause diabetes. It has not been reported to cause diabetes. However, Amlopin M might increase your blood sugar levels slightly, healthy people can tolerate it easily while diabetic patients might face some spike in blood sugar levels. So, if you have diabetes keep a check on your blood sugar levels and in case of a sudden spike inform your doctor and take medicines accordingly.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
No, use of Amlopin M has not been associated with memory loss. But if you are in doubt do discuss with your doctor to check for underlying medical conditions resulting in memory loss.
Amlopin M is a brand name of amlodipine. It is a prescription drug that belongs to the class of medications called calcium channel blocker. It is available in solid oral dosage forms like tablet and capsule. It is used in the treatment of high blood pressure (high BP) and coronary artery disease. It is not recommended for heart failure. It is also used in the treatment of angina (chest pain).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850